It was reported to valeritas customer care that diabetic patient (pt).Type 2 using the v-go 40 since (b)(6) 2014 experienced an abscess on his abdomen while using the v-go.According to the valeritas adverse event (ae) assessor, the patient stated that on (b)(6)2014, he removed the v-go from his left abdominal area, noticed a red mark and after a few days the red mark became "much larger, was hot, hard and very painful to touch".Patient reports he went to the emergency room on (b)(6) 2014, the abscess was drained and packed.Patient was not hospitalized.Patient states the drainage is still continuing (patient was not able to describe drainage amount or color), the site is very red and tender, the size of silver dollar.Patient was given a prescription and instructed to start antibiotics immediately (name of antibiotic unknown by patient), however patient has not filled the antibiotic prescription and states he will not be able to start the antibiotic till (b)(6) 2014 due to financial reasons.Ae assessor instructed patient to contact his hcp right away to discuss with hcp that he has not started the antibiotic.Patient is currently off the v-go for financial reasons, he was not discontinued from v-go by hcp.
|